These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 29409457

  • 1. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Martinez-Useros J, Moreno I, Fernandez-Aceñero MJ, Rodriguez-Remirez M, Borrero-Palacios A, Cebrian A, Gomez Del Pulgar T, Del Puerto-Nevado L, Li W, Puime-Otin A, Perez N, Soengas MS, Garcia-Foncillas J.
    BMC Cancer; 2018 Feb 06; 18(1):144. PubMed ID: 29409457
    [Abstract] [Full Text] [Related]

  • 2. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S, Nguyen N, Mohammadianpanah M, Mirzaei S, Bananzadeh AM.
    J Gastrointest Cancer; 2019 Dec 06; 50(4):716-722. PubMed ID: 29984382
    [Abstract] [Full Text] [Related]

  • 3. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1455-61. PubMed ID: 17445998
    [Abstract] [Full Text] [Related]

  • 4. Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer.
    Gómez Del Pulgar T, Cebrián A, Fernández-Aceñero MJ, Borrero-Palacios A, Del Puerto-Nevado L, Martínez-Useros J, Marín-Arango JP, Caramés C, Vega-Bravo R, Rodríguez-Remírez M, Cruz-Ramos M, Manzarbeitia F, García-Foncillas J.
    J Cell Mol Med; 2016 Sep 01; 20(9):1729-36. PubMed ID: 27171907
    [Abstract] [Full Text] [Related]

  • 5. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Daniel ES, Gibbs P, Guerrieri M, Faragher I.
    Colorectal Dis; 2014 Oct 01; 16(10):783-7. PubMed ID: 24786681
    [Abstract] [Full Text] [Related]

  • 6. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
    Clarke TL, White DA, Osborne ME, Shaw AM, Smart NJ, Daniels IR.
    Ann R Coll Surg Engl; 2017 May 01; 99(5):373-377. PubMed ID: 28462648
    [Abstract] [Full Text] [Related]

  • 7. Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
    Bampo C, Alessi A, Fantini S, Bertarelli G, de Braud F, Bombardieri E, Valvo F, Crippa F, Di Bartolomeo M, Mariani L, Milione M, Biondani P, Avuzzi B, Chiruzzi C, Pietrantonio F.
    Oncology; 2013 May 01; 84(4):191-9. PubMed ID: 23328390
    [Abstract] [Full Text] [Related]

  • 8. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A.
    Dis Colon Rectum; 2013 Jul 01; 56(7):859-68. PubMed ID: 23739192
    [Abstract] [Full Text] [Related]

  • 9. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C, Forlin M, Delrio P, Rega D, Degiuli M, Sofia S, Olivieri M, Pucciarelli S, Zuin M, De Manzoni G, Di Leo A, Scabini S, Zorcolo L, Restivo A.
    BMC Cancer; 2018 Nov 12; 18(1):1094. PubMed ID: 30419864
    [Abstract] [Full Text] [Related]

  • 10. Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer.
    Conde-Muíño R, Cuadros M, Zambudio N, Segura-Jiménez I, Cano C, Palma P.
    Biomed Res Int; 2015 Nov 12; 2015():921435. PubMed ID: 26504848
    [Abstract] [Full Text] [Related]

  • 11. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y, Wexner SD, Berho M.
    Colorectal Dis; 2012 May 12; 14(5):555-61. PubMed ID: 21689364
    [Abstract] [Full Text] [Related]

  • 12. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R, Duregon E, Sonetto C, Spadi R, Mistrangelo M, Racca P, Chiusa L, Munoz FH, Ricardi U, Arezzo A, Cassenti A, Castellano I, Papotti M, Morino M, Risio M, Cassoni P.
    PLoS One; 2015 May 12; 10(4):e0123759. PubMed ID: 25875173
    [Abstract] [Full Text] [Related]

  • 13. A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
    Dalle Fratte C, Mezzalira S, Polesel J, De Mattia E, Palumbo A, Buonadonna A, Palazzari E, De Paoli A, Belluco C, Canzonieri V, Toffoli G, Cecchin E.
    Oncol Res; 2022 Jan 31; 28(9):847-855. PubMed ID: 34108073
    [Abstract] [Full Text] [Related]

  • 14. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.
    Zhu K, Zhao Q, Yue J, Shi P, Yan H, Xu X, Wang R.
    Oncotarget; 2016 Oct 18; 7(42):68328-68338. PubMed ID: 27634904
    [Abstract] [Full Text] [Related]

  • 15. Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy.
    Landi F, Espín E, Rodrigues V, Vallribera F, Martinez A, Charpy C, Brunetti F, Azoulay D, de'Angelis N.
    Int J Colorectal Dis; 2017 Feb 18; 32(2):255-264. PubMed ID: 27757541
    [Abstract] [Full Text] [Related]

  • 16. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
    Lin CY, Hsieh PL, Chou CL, Yang CC, Lee SW, Tian YF, Shiue YL, Li WS.
    Oncology; 2020 Feb 18; 98(8):549-557. PubMed ID: 32408308
    [Abstract] [Full Text] [Related]

  • 17. The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Reynolds IS, McNamara DA, Kay EW, O'Neill B, Deasy J, Burke JP.
    J Surg Oncol; 2018 Dec 18; 118(7):1129-1134. PubMed ID: 30261095
    [Abstract] [Full Text] [Related]

  • 18. IMMUNOEXPRESSION OF DEK AND PHOSPHO-P38 PROTEINS IN RECTAL CANCER BEFORE CHEMORADIATION THERAPY.
    Tadokoro RB, Cardili L, Artigiani Neto R, Paiotti APR, Oshima CTF, Forones NM.
    Arq Gastroenterol; 2022 Dec 18; 59(3):414-420. PubMed ID: 36102441
    [Abstract] [Full Text] [Related]

  • 19. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD, Li J, Jeganathan AN, Mahmoud NN, Epstein AJ, Paulson EC.
    Dis Colon Rectum; 2016 Aug 18; 59(8):710-7. PubMed ID: 27384088
    [Abstract] [Full Text] [Related]

  • 20. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Reggiani Bonetti L, Lionti S, Domati F, Pagliani G, Mattioli E, Barresi V.
    Histopathology; 2017 Sep 18; 71(3):393-405. PubMed ID: 28425130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.